Rivaroxaban For Suspension shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Sep 18, 2026 · last update Sep 18, 2026
Manufacturers: Janssen Pharmaceuticals
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Xarelto, For Suspension, 155 mg (NDC 50458-575-01) | Janssen Pharmaceuticals | To Be Discontinued | — | Business Decision | Posted Sep 18, 2026 Updated Sep 18, 2026 Discontinued Sep 18, 2026 |